High Dose PPI denied due to quantity / dose limits by Cigna?

Cigna's specific coverage criteria for high dose ppi are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Applies Quantity Limits to High-Dose PPI

Cigna's pharmacy benefit typically caps the quantity of proton pump inhibitor dispensed per fill or per month to align with the dosing regimen stated in the FDA-approved prescribing label for the most common indications. When a prescriber orders a quantity that exceeds that built-in limit — whether due to a higher dose, more frequent administration, or a longer treatment duration — the claim triggers an automatic quantity-limit edit and is denied or reduced.

This is one of the most straightforward PPI denials to appeal, because quantity-limit edits are administrative rules, not clinical judgments. The appeal succeeds when documentation demonstrates that the prescribed quantity is medically necessary and consistent with the prescribing label or with recognized clinical guidelines for the patient's specific diagnosis.

## Federal Appeal Rights

• ACA §2719 / external review: Any quantity-limit denial that constitutes an adverse benefit determination is subject to internal and then external review. The external-review window is generally approximately four months from the denial date; your denial letter will state the exact deadline. Expedited review is available if your condition is urgent.
• ERISA §503: Self-funded plans must provide the specific quantity-limit criterion applied and a meaningful chance to rebut it.

## What to Gather

1. Diagnosis and severity documentation — chart notes and any relevant objective studies establishing the condition requiring the prescribed quantity. 2. Prescriber justification letter — explains why the standard dispensed quantity is clinically insufficient and what harm (symptom recurrence, mucosal injury, etc.) would result from undertreatment. 3. FDA label reference — if the prescribed quantity falls within any labeled indication's dosing range, highlight that passage. 4. Prior treatment outcomes — documentation that lower quantities or doses were tried and were inadequate. 5. Applicable guideline organization reference — e.g., the American College of Gastroenterology, without citing specific numeric thresholds that could be challenged.

## Criteria-Mapping Structure

Request a copy of Cigna's quantity-limit policy for this drug. Map each stated criterion to a specific fact in the medical record:

| Cigna Quantity-Limit Criterion | Supporting Chart Documentation | |---|---| | Each stated requirement | Exact note, date, or test result |

Present this table in your appeal letter so every requirement is addressed in a verifiable, reviewable format.